logo

NVO

Novo Nordisk·NYSE
--
--(--)
--
--(--)
5.72 / 10
Netural

Analyst coverage is neutral, with two analysts rating Novo Nordisk as Neutral and mixed historical returns. Fund‑flow metrics are strong (7.7/10), showing solid inflows (~48%) despite a negative trend across all investor sizes, suggesting continued buying pressure.

FundamentalSentiment(5.72)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-03-02
InstitutionGoldman Sachs
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for NVO?
  • NVO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.72/10 (Netural).